Traduction de «type a hepatitis » (Anglais → Français) :

hepatitis A | HA | type A hepatitis | viral hepatitis A | type A viral hepatitis | viral hepatitis type A | virus A hepatitis | acute viral hepatitis A | acute virus A hepatitis

Hepatitis Awareness Month Act [ An Act to provide for a Hepatitis Awareness Month ]

contagious hepatitis | epidemic hepatitis | hepatitis A | infectious hepatitis | viral hepatitis type A

serum hepatitis | transfusion hepatitis | viral hepatitis type B

hepatitis E | HE | viral hepatitis type E | viral hepatitis E | type E viral hepatitis | enterically transmitted non-A, non-B hepatitis

hepatitis C | HC | viral hepatitis type C | virus C hepatitis | viral hepatitis C | type C hepatitis | type C viral hepatitis

anti-HAV IgG | hepatitis A antibody of the IgG class | hepatitis A IgG | IgG antibody to hepatitis A virus

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

non-A, non-B hepatitis [ non-A-non-B hepatitis ]

hepatitis A [ infectious hepatitis ]

In my remarks I will try to concentrate on hepatitis C. We have been told today that there are many types of hepatitis, but hepatitis C is perhaps what has initiated this bill and is the type that most concerns us.

There are three types of illnesses covered by this legislation, and a certain number of people who would be the beneficiaries of the legislation. The illnesses are HIV, hepatitis A, hepatitis B, and hepatitis C, and the people covered by this are firefighters, medical practitioners, people who are taking care of sick people, peace officers, security officers, and people who are involved in the arrest of some individuals.

What I need to know is, do you also recommend the testing of some latent diseases such as hepatitis B; hepatitis C, which could lead to hepatoma; type 2 diabetes; non-specific types of STDs; genetic screening for DNA disorders; post-traumatic stress syndromes; or other psychiatric factors that need to be addressed?

(Return tabled) Question No. 361 Hon. Bob Rae: With regard to the projected impacts of Bill C-10, An Act to enact the Justice for Victims of Terrorism Act and to amend the State Immunity Act, the Criminal Code, the Controlled Drugs and Substances Act, the Corrections and Conditional Release Act, the Youth Criminal Justice Act, the Immigration and Refugee Protection Act and other Acts, on the number of inmates and their conditions of incarceration: (a) does the government have an estimate of how many new inmates this Bill is likely to create, and, if so, what is it; (b) how many new federal inmates does the government expect will result from this Bill; (c) how many new provincial inmates does the government expect will result from this Bil ...[+++]l, and has the government shared this estimate with the provinces; (d) how many new young offenders does the government expect will result from this Bill and has the government shared this estimate with the provinces; (e) how many new inmates is CSC planning for as a direct result of this bill; (f) how will this Bill affect the federal incarceration rate of aboriginals, broken down geographically and by sex; (g) how will this Bill affect the provincial incarceration rate of aboriginals, broken down geographically and by sex; (h) how will this Bill affect the youth incarceration rate of aboriginals, broken down geographically and by sex; (i) what resources will be allocated to meet the unique needs of the aboriginal offenders, broken down geographically and by sex; (j) what resources will be allocated to meet the needs of the increased aboriginal offender population, broken down geographically and by sex; (k) how many new staff does CSC anticipate will need to be hired as a result of this Bill, broken down by job type; (l) has CSC planned for additional programming to accommodate the influx of new inmates resulting from this Bill, and, if so, how many new programming spaces will be created, broken down by type; (m) how is ...